FEROZ Ferozsons Laboratories Limited

Ferozsons Laboratories Limited (FEROZ) financial ratios

Ferozsons Laboratories Limited earned a net margin of 5.1% in FY2026 against a five-year average of 5.2% (Pharmaceuticals median 9.4%). Return on equity was 7.6%, compared with a sector median of 21.7%. The current ratio stood at 1.87× and debt was 27.3% of equity. Cash took about 166 days to cycle through receivables, inventory and payables.

FY2026 vs the Pharmaceuticals median

Gross margin: 44.7%; Sector median 37.0%
Operating margin: 10.3%; Sector median 17.3%
Net margin: 5.1%; Sector median 9.4%
Return on equity (ROE): 7.6%; Sector median 21.7%
Return on assets (ROA): 4.9%; Sector median 11.7%
Current ratio: 1.87×; Sector median 1.79×
Debt to equity: 27.3%; Sector median 5.8%
Asset turnover: 0.95×; Sector median 1.26×
Dividend payout ratio: 17.8%; Sector median 32.8%

Median of the 14 companies in the sector with the figure for their latest fiscal year.

FEROZ financial ratios (annual) (Rs mn)
Rs mn	FY2026 Jul 2025 – Jun 2026	FY2025 Jul 2024 – Jun 2025	FY2024 Jul 2023 – Jun 2024	FY2023 Jul 2022 – Jun 2023	FY2022 Jul 2021 – Jun 2022	FY2021 Jul 2020 – Jun 2021	FY2020 Jul 2019 – Jun 2020	FY2019 Jul 2018 – Jun 2019	FY2018 Jul 2017 – Jun 2018	FY2017 Jul 2016 – Jun 2017	FY2016 Jul 2015 – Jun 2016	FY2015 Jul 2014 – Jun 2015	FY2014 Jul 2013 – Jun 2014	FY2013 Jul 2012 – Jun 2013	FY2012 Jul 2011 – Jun 2012	FY2011 Jul 2010 – Jun 2011	FY2010 Jul 2009 – Jun 2010	FY2009 * Jul 2008 – Jun 2009	FY2008 * Jul 2007 – Jun 2008	FY2007 * Jul 2006 – Jun 2007
Profitability
Gross margin	44.7%	42.4%	40.8%	37.2%	42.7%	41.3%	37.4%	35.2%	31.6%	38.2%	40.5%	45.4%	47.7%	48.0%	47.2%	51.2%	45.4%	50.9%	54.8%	52.2%
EBITDA margin	14.6%	14.9%	13.4%	8.0%	15.2%	20.4%	14.2%	11.4%	8.9%	17.9%	26.8%	27.1%	23.3%	22.2%	23.2%	30.1%	29.0%	28.3%	34.2%	34.1%
Operating margin	10.3%	9.9%	10.0%	3.8%	10.7%	16.0%	8.0%	4.6%	1.7%	11.3%	24.7%	23.6%	18.7%	17.0%	18.2%	24.1%	21.9%	24.5%	30.9%	29.8%
Pre-tax margin	8.4%	8.1%	7.0%	3.6%	13.3%	17.6%	9.6%	5.8%	1.7%	11.8%	25.2%	23.8%	19.9%	18.2%	17.8%	23.0%	17.0%	20.9%	28.8%	25.9%
Net margin	5.1%	4.9%	4.8%	2.6%	8.5%	14.5%	6.8%	3.2%	(0.3%)	7.9%	19.7%	16.5%	14.4%	16.2%	17.2%	19.3%	15.9%	9.8%	13.4%	13.6%
Effective tax rate	39.1%	39.6%	31.7%	28.6%	36.1%	17.7%	28.6%	44.4%	119.9%	33.3%	21.9%	30.6%	27.4%	10.8%	3.3%	16.1%	6.6%	53.2%	53.6%	47.6%
Returns
Return on equity (ROE)	7.6%	6.6%	7.1%	3.5%	9.6%	16.9%	7.0%	3.7%	0.1%	7.1%	48.3%	27.7%	18.3%	17.6%	21.1%	23.3%	19.4%	10.1%	13.6%	16.0%
Return on assets (ROA)	4.9%	4.0%	3.9%	1.9%	6.1%	12.3%	5.3%	2.7%	(0.2%)	5.8%	36.9%	21.0%	15.7%	14.8%	17.1%	18.7%	13.1%	7.0%	9.6%	12.2%
Return on invested capital (ROIC)	6.4%	6.2%	7.8%	4.3%	8.0%	15.1%	6.9%	3.7%	0.1%	6.9%	46.5%	26.7%	18.0%	17.5%	20.4%	21.6%	17.9%	8.0%	11.2%	14.6%
Liquidity
Current ratio	1.87×	1.94×	1.61×	1.55×	2.29×	2.81×	2.72×	3.19×	3.32×	4.27×	4.67×	2.39×	4.04×	4.49×	3.48×	2.66×	1.89×	1.76×	2.25×	2.51×
Quick ratio	0.65×	0.92×	0.79×	0.61×	1.33×	1.97×	1.54×	2.09×	2.08×	2.02×	2.10×	1.40×	2.33×	2.25×	2.13×	1.20×	0.79×	0.71×	1.43×	1.71×
Leverage
Debt to equity	27.3%	29.7%	41.6%	43.3%	27.1%	14.9%	2.7%	0.4%	1.8%	0.4%	0.7%	0.1%	0.0%	0.0%	0.0%	5.8%	14.2%	21.5%	25.3%	10.1%
Debt to capital	21.4%	22.9%	29.4%	30.2%	21.3%	12.9%	2.6%	0.4%	1.8%	0.4%	0.7%	0.1%	0.0%	0.0%	0.0%	5.5%	12.5%	17.7%	20.2%	9.2%
Debt to assets	16.4%	17.4%	22.6%	21.8%	16.1%	9.8%	2.0%	0.3%	1.4%	0.4%	0.6%	0.0%	0.0%	0.0%	0.0%	4.6%	10.6%	15.4%	17.6%	7.7%
Assets to equity	1.68×	1.76×	1.90×	1.83×	1.60×	1.44×	1.31×	1.25×	1.22×	1.19×	1.28×	1.32×	1.19×	1.19×	1.24×	1.29×	1.36×	1.41×	1.38×	1.27×
Efficiency
Asset turnover	0.95×	0.81×	0.83×	0.75×	0.72×	0.85×	0.77×	0.82×	0.73×	0.73×	1.88×	1.27×	1.09×	0.92×	0.99×	0.97×	0.82×	0.71×	0.72×	0.90×
Receivable days days	45	56	51	50	64	58	66	56	40	31	13	17	21	37	35	24	20	17	18	31
Inventory days days	220	198	198	213	183	147	163	135	178	241	96	136	160	177	149	169	148	150	134	113
Payable days days	99	93	109	147	156	129	125	84	54	47	39	84	53	65	60	53	38	29	38	56
Cash conversion cycle days	166	160	139	116	90	77	104	107	164	225	70	69	127	149	125	139	130	138	113	87
Dividends
Dividend payout ratio	17.8%	16.8%	0.0%	66.8%	49.3%	10.3%	29.0%	60.1%	0.9%	30.5%	16.4%	63.4%	68.9%	46.4%	45.5%	15.6%	0.0%	14.9%	31.6%	57.0%
Earnings retention rate	0.82×	0.83×	1.00×	0.33×	0.51×	0.90×	0.71×	0.40×	0.99×	0.69×	0.84×	0.37×	0.31×	0.54×	0.55×	0.84×	1.00×	0.85×	0.68×	0.43×

Ratios as reported for each fiscal year; returns are on average equity / assets. Debt ratios are percentages; turnover in times; working-capital measures in days.

FEROZ: frequently asked questions

What is FEROZ's EPS?

Ferozsons Laboratories Limited reported basic earnings per share of Rs 22.51 for FY2026 (Jul 2025 – Jun 2026).

What is FEROZ's P/E ratio?

At the closing price of Rs 335.22 on 16 Oct 2026, FEROZ trades at a P/E of 14.9× based on EPS of Rs 22.51 (FY2026).

Does FEROZ pay dividends?

Yes. Ferozsons Laboratories Limited declared a dividend of Rs 5.50 per share for FY2026. It has paid a dividend in each of the last 3 years. At Rs 335.22 that is a dividend yield of 1.6%.

What was FEROZ's revenue and profit in FY2026?

Ferozsons Laboratories Limited reported revenue of Rs 24.0 bn and profit attributable to shareholders of Rs 978.6 mn for FY2026 (Jul 2025 – Jun 2026).

What is FEROZ's book value per share?

Ferozsons Laboratories Limited's book value per share was Rs 304.56 at the end of FY2026. The shares trade at 1.10× book value.

Information only, not investment advice.